Literature DB >> 11924763

Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots.

D Wu1, L Yu, M G Nair, D L DeWitt, R S Ramsewak.   

Abstract

Cyclooxygenase enzyme inhibitory assay-guided purification of ethyl acetate extract of Piper methysticum (kava kava) roots yielded six biologically active compounds (1-7), which were purified using MPLC, preparative TLC and HPLC methods. These compounds were also evaluated for antioxidant activities. Dihydrokawain (1) and yangonin (6) showed the highest COX-I and COX-II inhibitory activities at 100 microg/ml, respectively. The lipid oxidation assay did not reveal antioxidant activities for demethoxyangonin (2), dihydrokawain (1), kawain (4), dihydromethysticin (5) or methysticin (7) at 50 microg/ml. The antioxidant activities of flavokawain A (3) and yangonin (6) could not be tested in the lipid oxidation assay due to solubility problems. However, yangonin and methysticin showed moderate antioxidant activities in the free radical scavenging assay at 2.5 mg/ml.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11924763     DOI: 10.1078/0944-7113-00068

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  13 in total

1.  Botanical dietary supplements gone bad.

Authors:  Birgit Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2007-03-16       Impact factor: 3.739

Review 2.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

3.  In vitro antitrypanosomal activity of some phenolic compounds from propolis and lactones from Fijian Kawa (Piper methysticum).

Authors:  Kazuhiko Otoguro; Masato Iwatsuki; Aki Ishiyama; Miyuki Namatame; Aki Nishihara-Tsukashima; Hiroaki Kiyohara; Toshihiro Hashimoto; Yoshinori Asakawa; Satoshi Omura; Haruki Yamada
Journal:  J Nat Med       Date:  2011-11-25       Impact factor: 2.343

4.  Age-related protective effect of deprenyl on changes in the levels of diagnostic marker enzymes and antioxidant defense enzymes activities in cerebellar tissue in Wistar rats.

Authors:  Manju V Subramanian; T J James
Journal:  Cell Stress Chaperones       Date:  2010-03-13       Impact factor: 3.667

5.  Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.

Authors:  Yan Li; Hu Mei; Qiangen Wu; Suhui Zhang; Jia-Long Fang; Leming Shi; Lei Guo
Journal:  Toxicol Sci       Date:  2011-09-09       Impact factor: 4.849

Review 6.  Toxicity of kava kava.

Authors:  Peter P Fu; Qingsu Xia; Lei Guo; Hongtao Yu; Po-Chuen Chan
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2008 Jan-Mar       Impact factor: 3.781

7.  Neuroprotective properties of kavalactones.

Authors:  Yew-Min Tzeng; Meng-Jen Lee
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

Review 8.  Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Authors:  Flaminia Pantano; Roberta Tittarelli; Giulio Mannocchi; Simona Zaami; Serafino Ricci; Raffaele Giorgetti; Daniela Terranova; Francesco P Busardò; Enrico Marinelli
Journal:  Int J Mol Sci       Date:  2016-04-16       Impact factor: 5.923

9.  Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.

Authors:  Athanassios Fragoulis; Stephanie Siegl; Markus Fendt; Sandra Jansen; Ulf Soppa; Lars-Ove Brandenburg; Thomas Pufe; Joachim Weis; Christoph Jan Wruck
Journal:  Redox Biol       Date:  2017-04-19       Impact factor: 11.799

10.  Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.

Authors:  Karen M Savage; Con K Stough; Gerard J Byrne; Andrew Scholey; Chad Bousman; Jenifer Murphy; Patricia Macdonald; Chao Suo; Matthew Hughes; Stuart Thomas; Rolf Teschke; Chengguo Xing; Jerome Sarris
Journal:  Trials       Date:  2015-11-02       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.